|
|
|
Volumn 41, Issue SUPPL. A, 2005, Pages 1-4
|
|
Endometriosis market research: An overview of findings in Europe and the United States
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOOXYGENASE 2 INHIBITOR;
DANAZOL;
GESTAGEN;
GONADORELIN AGONIST;
LEUPRORELIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
ORAL CONTRACEPTIVE AGENT;
ANAMNESIS;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
DIAGNOSTIC TEST;
DISEASE SEVERITY;
ECHOGRAPHY;
ENDOMETRIOSIS;
EUROPE;
FRANCE;
GERMANY;
HUMAN;
LAPAROSCOPY;
PATIENT CARE;
PELVIS PAIN SYNDROME;
PHYSICAL EXAMINATION;
PRACTICE GUIDELINE;
PREOPERATIVE CARE;
PRESCRIPTION;
RELIABILITY;
SYMPTOM;
UNITED STATES;
ENDOMETRIOSIS;
EUROPE;
FEMALE;
HUMANS;
UNITED STATES;
|
|
EID: 23444433896
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (3)
|
